ArticleClinical and molecular hepatology2026

Beyond the single model: Critical considerations for translating HCC triplet immunotherapy from bench to bedside: Letter to the editor on "Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinoma".

Han Zhuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.